Annual Shareholders Equity
-$11.62 M
-$9.05 M-352.39%
31 December 2023
Summary:
Fennec Pharmaceuticals annual stockholders equity is currently -$11.62 million, with the most recent change of -$9.05 million (-352.39%) on 31 December 2023. During the last 3 years, it has fallen by -$40.69 million (-139.98%). FENC annual shareholders equity is now -135.22% below its all-time high of $33.00 million, reached on 30 June 2004.FENC Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$5.17 M
-$3.81 M-281.06%
30 September 2024
Summary:
Fennec Pharmaceuticals quarterly stockholders equity is currently -$5.17 million, with the most recent change of -$3.81 million (-281.06%) on 30 September 2024. Over the past year, it has increased by +$5.36 million (+50.90%). FENC quarterly shareholders equity is now -114.31% below its all-time high of $36.13 million, reached on 30 June 2020.FENC Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FENC Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -352.4% | +50.9% |
| 3 y3 years | -140.0% | -127.2% |
| 5 y5 years | -154.5% | -134.5% |
FENC Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -140.0% | at low | -127.2% | +55.5% |
| 5 y | 5 years | -140.0% | at low | -114.3% | +55.5% |
| alltime | all time | -135.2% | at low | -114.3% | +55.5% |
Fennec Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$5.17 M(+281.1%) |
| June 2024 | - | -$1.36 M(-145.0%) |
| Mar 2024 | - | $3.01 M(-125.9%) |
| Dec 2023 | -$11.62 M(+352.4%) | -$11.62 M(+10.4%) |
| Sept 2023 | - | -$10.53 M(+8.3%) |
| June 2023 | - | -$9.73 M(+32.5%) |
| Mar 2023 | - | -$7.34 M(+185.7%) |
| Dec 2022 | -$2.57 M(-116.3%) | -$2.57 M(-191.7%) |
| Sept 2022 | - | $2.80 M(-67.2%) |
| June 2022 | - | $8.54 M(-31.8%) |
| Mar 2022 | - | $12.52 M(-20.6%) |
| Dec 2021 | $15.77 M(-45.7%) | $15.77 M(-17.0%) |
| Sept 2021 | - | $19.01 M(-14.7%) |
| June 2021 | - | $22.28 M(-10.6%) |
| Mar 2021 | - | $24.93 M(-14.2%) |
| Dec 2020 | $29.07 M(+144.8%) | $29.07 M(-6.8%) |
| Sept 2020 | - | $31.18 M(-13.7%) |
| June 2020 | - | $36.13 M(+327.0%) |
| Mar 2020 | - | $8.46 M(-28.7%) |
| Dec 2019 | $11.88 M(-44.3%) | $11.88 M(-20.8%) |
| Sept 2019 | - | $15.00 M(-8.9%) |
| June 2019 | - | $16.48 M(-14.2%) |
| Mar 2019 | - | $19.21 M(-9.9%) |
| Dec 2018 | $21.31 M(-20.3%) | $21.31 M(-6.8%) |
| Sept 2018 | - | $22.86 M(-8.0%) |
| June 2018 | - | $24.86 M(-3.1%) |
| Mar 2018 | - | $25.66 M(-4.1%) |
| Dec 2017 | $26.76 M(+649.5%) | $26.76 M(+202.1%) |
| Sept 2017 | - | $8.86 M(-8.5%) |
| June 2017 | - | $9.68 M(+238.3%) |
| Mar 2017 | - | $2.86 M(-19.9%) |
| Dec 2016 | $3.57 M(+551.5%) | $3.57 M(-15.4%) |
| Sept 2016 | - | $4.22 M(-9.3%) |
| June 2016 | - | $4.65 M(+1814.8%) |
| Mar 2016 | - | $243.00 K(-55.7%) |
| Dec 2015 | $548.00 K(-10.6%) | $548.00 K(-46.2%) |
| Sept 2015 | - | $1.02 M(-8.4%) |
| June 2015 | - | $1.11 M(+34.6%) |
| Mar 2015 | - | $826.00 K(+34.7%) |
| Dec 2014 | $613.00 K(-142.1%) | $613.00 K(-119.0%) |
| Sept 2014 | - | -$3.23 M(-30.7%) |
| June 2014 | - | -$4.66 M(+7.5%) |
| Mar 2014 | - | -$4.33 M(+197.9%) |
| Dec 2013 | -$1.46 M(-70.6%) | -$1.46 M(-64.7%) |
| Sept 2013 | - | -$4.13 M(+69.9%) |
| June 2013 | - | -$2.43 M(-73.2%) |
| Mar 2013 | - | -$9.06 M(+82.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | -$4.96 M(+4030.8%) | -$4.96 M(-486.1%) |
| Sept 2012 | - | $1.28 M(-37.2%) |
| June 2012 | - | $2.04 M(-21.2%) |
| Mar 2012 | - | $2.60 M(-2262.5%) |
| Dec 2011 | -$120.00 K(-97.6%) | -$120.00 K(-96.7%) |
| Sept 2011 | - | -$3.67 M(+436.5%) |
| June 2011 | - | -$684.00 K(+140.0%) |
| Mar 2011 | - | -$285.00 K(-94.2%) |
| Dec 2010 | -$4.92 M(-1312.8%) | -$4.92 M(-406.8%) |
| Sept 2010 | - | $1.60 M(-437.2%) |
| June 2010 | - | -$476.00 K(-1290.0%) |
| Mar 2010 | - | $40.00 K(-90.1%) |
| Dec 2009 | $406.00 K(-86.7%) | $406.00 K(+8.0%) |
| Sept 2009 | - | $376.00 K(-6.5%) |
| June 2009 | - | $402.00 K(-63.7%) |
| Mar 2009 | - | $1.11 M(-63.7%) |
| Dec 2008 | $3.05 M(-78.4%) | $3.05 M(-40.8%) |
| Sept 2008 | - | $5.15 M(-37.0%) |
| June 2008 | - | $8.18 M(-26.8%) |
| Mar 2008 | - | $11.18 M(-21.0%) |
| Dec 2007 | $14.15 M(+1015.8%) | $14.15 M(-14.9%) |
| Sept 2007 | - | $16.63 M(-14.6%) |
| June 2007 | - | $19.47 M(-5.9%) |
| Mar 2007 | - | $20.70 M(+1532.5%) |
| Dec 2006 | $1.27 M(-93.7%) | $1.27 M(-90.8%) |
| Sept 2006 | - | $13.81 M(-26.0%) |
| June 2006 | - | $18.66 M(+11.9%) |
| Mar 2006 | - | $16.68 M(-16.8%) |
| Dec 2005 | $20.06 M(-39.2%) | $20.06 M(-25.2%) |
| Sept 2005 | - | $26.82 M(+18.2%) |
| June 2005 | - | $22.69 M(-14.5%) |
| Mar 2005 | - | $26.53 M(-17.9%) |
| Sept 2004 | - | $32.33 M(-2.0%) |
| June 2004 | $33.00 M(+115.6%) | $33.00 M(+20.1%) |
| Mar 2004 | - | $27.47 M(-9.7%) |
| Dec 2003 | - | $30.41 M(+122.0%) |
| Sept 2003 | - | $13.70 M(-10.5%) |
| June 2003 | $15.31 M(+151.6%) | $15.31 M(+4.9%) |
| Mar 2003 | - | $14.59 M(-4.0%) |
| Dec 2002 | - | $15.20 M(+223.8%) |
| Sept 2002 | - | $4.69 M(-22.9%) |
| June 2002 | $6.09 M(-38.0%) | $6.09 M(-13.7%) |
| Mar 2002 | - | $7.05 M(-11.2%) |
| Dec 2001 | - | $7.94 M(-7.1%) |
| Sept 2001 | - | $8.55 M(-12.9%) |
| June 2001 | $9.82 M(>+9900.0%) | $9.82 M(+77.9%) |
| Dec 2000 | - | $5.52 M |
| June 2000 | $46.70 K | - |
FAQ
- What is Fennec Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals annual shareholders equity year-on-year change?
- What is Fennec Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Fennec Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of FENC is -$11.62 M
What is the all time high annual shareholders equity for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual stockholders equity is $33.00 M
What is Fennec Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, FENC annual stockholders equity has changed by -$9.05 M (-352.39%)
What is Fennec Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of FENC is -$5.17 M
What is the all time high quarterly shareholders equity for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly stockholders equity is $36.13 M
What is Fennec Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, FENC quarterly stockholders equity has changed by +$5.36 M (+50.90%)